BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quader S, Kataoka K, Cabral H. Nanomedicine for brain cancer. Adv Drug Deliv Rev 2022;182:114115. [PMID: 35077821 DOI: 10.1016/j.addr.2022.114115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ahmed T, Liu FF, Lu B, Lip H, Park E, Alradwan I, Liu JF, He C, Zetrini A, Zhang T, Ghavaminejad A, Rauth AM, Henderson JT, Wu XY. Advances in Nanomedicine Design: Multidisciplinary Strategies for Unmet Medical Needs. Mol Pharm 2022. [PMID: 35587783 DOI: 10.1021/acs.molpharmaceut.2c00038] [Reference Citation Analysis]
2 Seung Lee J, Kim J, Ye YS, Kim TI. Materials and device design for advanced phototherapy systems. Adv Drug Deliv Rev 2022;186:114339. [PMID: 35568104 DOI: 10.1016/j.addr.2022.114339] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Liang R, Wu C, Liu S, Zhao W. Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers. Drug Deliv 2022;29:1620-30. [PMID: 35612318 DOI: 10.1080/10717544.2022.2075986] [Reference Citation Analysis]